SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma reports 15% rise in Q2 consolidated net profit

14 Nov 2014 Evaluate

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2014.

The company has posted a net loss of Rs 317.62 crore for the quarter under review as compared to a net profit of Rs 6.30 crore for the same quarter in the previous year. Total income of the company has decreased 16.03% at Rs 540.54 crore for Q2FY15 as compared Rs 643.74 crore for the corresponding quarter previous year.

On consolidated basis, the company’s net profit after taxes and minority interest for the quarter under review registered 15.43% growth at Rs 1572.46 crore against Rs 1362.30 crore in the September quarter of previous fiscal. The company’s total income has increased by 11.84% at Rs 4822.15 crore for the quarter from Rs 4311.63 crore in the similar quarter of previous year.

Pharmalucence Inc., a pharmaceutical company, incorporated in United States of America became a subsidiary of the company on July 16, 2014. Accordingly, the above results for the current periods include the relevant results of Pharmalucence Inc., from the date it became subsidiary of the company and therefore the corresponding figures for the previous periods are not comparable.

Sun Pharma Inds. Share Price

1675.20 -17.95 (-1.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×